UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000021479
Receipt No. R000024346
Scientific Title Effect of dapagliflozin, the sodium-glucose-cotransporter-2 (SGLT2) inhibitor, on fibroblast growth factor 21 (FGF21), a novel hepatokine and myokine, in Japanese patients of type 2 diabetes
Date of disclosure of the study information 2016/04/01
Last modified on 2020/06/19 18:08:58

No. Disposal Last modified on Item of update
1 Insert 2016/03/15 17:41:58
2 Update 2016/04/12 17:51:58 Name of primary sponsor
Institute
Organization
3 Update 2016/04/12 17:57:26 Primary outcomes
Primary outcomes
4 Update 2016/09/15 14:15:04 Recruitment status
5 Update 2016/09/15 14:18:08 Email1
6 Update 2017/09/16 19:08:15 Recruitment status
7 Update 2020/06/11 17:30:34 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization1
Organization
Organization
Address
Address
Tel
Email
8 Update 2020/06/11 17:34:06 Recruitment status
Date of IRB
Last follow-up date
9 Update 2020/06/19 18:08:58 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures


Contact us.